Wall Street's Analysis on Sientra Inc (SIEN) Stock's Recent Behavior

Wednesday, May 20, 2020 11:16 AM | InvestorsObserver Analysts

The market has been high on Sientra Inc (SIEN) stock recently. SIEN gets a Bullish score from InvestorsObserver's Stock Sentiment Indicator.

Sentiment Score - ,bullish
Sientra Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on SIEN!

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment.

Price action is generally the best indicator of sentiment. For a stock to go up, investors must feel good about it. Similarly, a stock that is in a downtrend must be out of favor.

InvestorsObserver’s Sentiment Indicator considers price action and recent trends in volume. Increasing volumes often mean that a trend is strengthening, while decreasing volumes can signal that a reversal could come soon.

The options market is another place to get signals about sentiment. Since options allow investors to place bets on the price of a stock, we consider the ratio of calls and puts for stocks where options are available.

What's Happening With SIEN Stock Today?

Sientra Inc (SIEN) stock has risen 13.57% while the S&P 500 has fallen -1.05% as of 11:14 AM on Wednesday, May 20. SIEN has risen $0.46 from the previous closing price of $3.39 on volume of 1,930,429 shares. Over the past year the S&P 500 has gained 2.91% while SIEN has fallen -45.77%. SIEN lost -$2.53 per share in the over the last 12 months.

To see the top 5 stocks in the Medical Devices industry click here.

More About Sientra Inc

Sientra Inc is a part of the healthcare sector in the United States. Its business involves the provision of silicone gel breast implants for use in breast augmentation and breast reconstruction procedures. Its operating segments are Breast Products and miraDry. The Breast Products segment focuses on sales of breast implants, tissue expanders and scar management products under the brands' OPUS, AlloX2, Dermaspan, Softspan, and BIOCORNEUM. The miraDry segment focuses on sales of the miraDry System and bioTips. Geographically, the firm generates a majority of its revenue from the United States.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

40% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 57% with annual

InvestorsObserver Premium

$ 20.75 $ 12.45 /month
$249 $149.40 billed annually

You May Also Like

Related Articles

Related Companies